B

Bright Minds Biosciences Inc
CNSX:DRUG

Watchlist Manager
Bright Minds Biosciences Inc
CNSX:DRUG
Watchlist
Price: 59 CAD 4.8% Market Closed
Market Cap: 263.4m CAD
Have any thoughts about
Bright Minds Biosciences Inc?
Write Note

Bright Minds Biosciences Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bright Minds Biosciences Inc
Operating Income Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
B
Bright Minds Biosciences Inc
CNSX:DRUG
Operating Income
-CA$7.4m
CAGR 3-Years
-148%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Operating Income
$9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Operating Income
-$116.2m
CAGR 3-Years
-30%
CAGR 5-Years
-55%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Operating Income
-$52.9m
CAGR 3-Years
29%
CAGR 5-Years
3%
CAGR 10-Years
-17%
Covalon Technologies Ltd
XTSX:COV
Operating Income
-CA$1.4m
CAGR 3-Years
48%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Operating Income
-CA$13.7m
CAGR 3-Years
-23%
CAGR 5-Years
-46%
CAGR 10-Years
-1%

See Also

What is Bright Minds Biosciences Inc's Operating Income?
Operating Income
-7.4m CAD

Based on the financial report for Sep 30, 2023, Bright Minds Biosciences Inc's Operating Income amounts to -7.4m CAD.

What is Bright Minds Biosciences Inc's Operating Income growth rate?
Operating Income CAGR 3Y
-148%

Over the last year, the Operating Income growth was 51%. The average annual Operating Income growth rates for Bright Minds Biosciences Inc have been -148% over the past three years .

Back to Top